Skip to main content

Table 1 Characteristics of the study population at baseline

From: Plasma procalcitonin is associated with all-cause and cancer mortality in apparently healthy men: a prospective population-based study

Characteristic

Population

Men

Women

PCT quartiles

Q1

Q2

Q3

Q4

Number of participants (%)

3,322

1,467 (44)

1,855 (56)

935

820

760

807

Age, mean (SD), years

58 (6)

58 (6)

58 (6)

56 (6)

57 (6)

58 (6)

59 (6)

Blood pressure, mean (SD), mm Hg

       

 Systolic

142 (19)

143 (18)

140 (19)

137 (18)

140 (18)

145 (19)

146 (19)

 Diastolic

87 (9)

89 (9)

86 (9)

85 (9)

86 (9)

88 (9)

89 (9)

Hypertension, Number (%)

2,118 (63.8)

991 (67.6)

1,127 (60.8)

508 (54.3)

506 (61.7)

510 (67.1)

594 (73.6)

Lipids, mean (SD), mmol/L

       

 LDL-C

4.17 (0.98)

4.12 (0.90)

4.20 (1.04)

4.05 (1.00)

4.11 (0.94)

4.30 (0.99)

4.22 (0.97)

 HDL-C

1.38 (0.37)

1.22 (0.29)

1.52 (0.37)

1.52 (0.38)

1.41 (0.36)

1.32 (0.35)

1.26 (0.33)

 TG

1.31 (0.63)

1.43 (0.68)

1.21 (0.57)

1.11 (1.00)

1.22 (0.55)

1.40 (0.66)

1.53 (0.73)

Body mass index, mean (SD), kg/m2

25.7 (3.9)

26.0 (3.4)

25.5 (4.2)

24.9 (3.7)

25.3 (3.7)

26.1 (3.7)

26.8 (4.0)

Diabetes mellitus, Number (%)

272 (8.2)

158 (10.8)

114 (6.1)

42 (4.5)

41 (5.0)

71 (9.3)

118 (14.6)

Current smoking, Number (%)

861 (25.9)

412 (28.1)

449 (24.2)

251 (26.8)

221 (27.0)

205 (27.0)

184 (22.8)

Cystatin C, mean (SD), mg/L

0.77 (0.14)

0.79 (0.15)

0.75 (0.13)

0.72 (0.12)

0.76 (0.12)

0.79 (0.13)

0.83 (0.17)

hsCRP, median (IQR), mg/L

0.13

0.12

0.13

0.10

0.11

0.13

0.20

(0.06 to 0.28)

(0.06 to 0.27)

(0.06 to 0.28)

(0.05 to 0.20)

(0.06 to 0.24)

(0.07 to 0.27)

(0.09 to 0.41)

PCT, median (IQR), pg/mL

16 (13 to 20)

18 (15 to 23)

14 (12 to 18)

12 (10 to 13)

15 (14 to 16)

18 (17 to 19)

25 (22 to 30)

 Men

   

14 (12 to 15)

17 (16 to 18)

20 (19 to 21)

28 (25 to 34)

 Women

   

10 (9 to 11)

13 (12 to 14)

16 (15 to 17)

21 (19 to 25)

  1. hsCRP, high sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol; IQR, interquartile range; LDL-C, low-density lipoprotein cholesterol; PCT, procalcitonin; TG, triglycerides.